209 related articles for article (PubMed ID: 16253950)
1. Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide.
Shi J; Yan WW; Qi XR; Maitani Y; Nagai T
Drug Deliv; 2005; 12(6):349-56. PubMed ID: 16253950
[TBL] [Abstract][Full Text] [Related]
2. [Biodistribution and hepatocytes targeting of cationic liposomes surface-modified with sterylglucoside and golyethylene glycol].
Shi J; Yan WW; Qi XR; Yang L; Zhang L
Yao Xue Xue Bao; 2004 Jul; 39(7):551-5. PubMed ID: 15493849
[TBL] [Abstract][Full Text] [Related]
3. Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol.
Qi XR; Yan WW; Shi J
World J Gastroenterol; 2005 Aug; 11(32):4947-52. PubMed ID: 16124043
[TBL] [Abstract][Full Text] [Related]
4. [Influence of soybean-derived sterylglucoside and amphipathic polyethylene glycol on the cellular delivery and anisotropy of different cationic liposomes].
Yan W; Fei R; Wang W; Qi X; Wei L; Cong X; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):324-8. PubMed ID: 12914258
[TBL] [Abstract][Full Text] [Related]
5. [Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro].
Shi J; Qi XR; Yang L; Fei R; Wei L
Yao Xue Xue Bao; 2006 Jan; 41(1):19-23. PubMed ID: 16683522
[TBL] [Abstract][Full Text] [Related]
6. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides.
Meyer O; Kirpotin D; Hong K; Sternberg B; Park JW; Woodle MC; Papahadjopoulos D
J Biol Chem; 1998 Jun; 273(25):15621-7. PubMed ID: 9624154
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.
Zhang Y; Rong Qi X; Gao Y; Wei L; Maitani Y; Nagai T
J Control Release; 2007 Feb; 117(2):281-90. PubMed ID: 17196291
[TBL] [Abstract][Full Text] [Related]
8. Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.
Shimizu K; Maitani Y; Takayama K; Nagai T
Biol Pharm Bull; 1997 Aug; 20(8):881-6. PubMed ID: 9300135
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
[TBL] [Abstract][Full Text] [Related]
10. [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35].
Zhang Y; Qi XR; Gao Y; Wei L
Yao Xue Xue Bao; 2006 Nov; 41(11):1111-5. PubMed ID: 17262957
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
[TBL] [Abstract][Full Text] [Related]
12. Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
Wyrozumska P; Meissner J; Toporkiewicz M; Szarawarska M; Kuliczkowski K; Ugorski M; Walasek MA; Sikorski AF
Cancer Biol Ther; 2015; 16(1):66-76. PubMed ID: 25482931
[TBL] [Abstract][Full Text] [Related]
13. Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.
Ko YT; Bhattacharya R; Bickel U
J Control Release; 2009 Feb; 133(3):230-7. PubMed ID: 19013203
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells.
Maitani Y; Kawano K; Yamada K; Nagai T; Takayama K
J Control Release; 2001 Aug; 75(3):381-9. PubMed ID: 11489324
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
[TBL] [Abstract][Full Text] [Related]
17. [Cationic liposomes enhance the inhibitory effects of antisense oligodeoxynucleotide on hepatitis B virus].
Yan W; Qi X; Wei L; Fei R; Wang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Dec; 35(6):629-33. PubMed ID: 14710259
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes.
Weecharangsan W; Opanasopit P; Yingyongnarongkul BE; Kewsuwan P; Lee RJ
Curr Pharm Biotechnol; 2014; 15(9):790-9. PubMed ID: 25307014
[TBL] [Abstract][Full Text] [Related]
19. Efficient transfer of intact oligonucleotides into the nucleus of ligament scar fibroblasts by HVJ-cationic liposomes is correlated with effective antisense gene inhibition.
Nakamura N; Hart DA; Frank CB; Marchuk LL; Shrive NG; Ota N; Taira K; Yoshikawa H; Kaneda Y
J Biochem; 2001 May; 129(5):755-9. PubMed ID: 11328598
[TBL] [Abstract][Full Text] [Related]
20. Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models.
Shimizu K; Qi XR; Maitani Y; Yoshii M; Kawano K; Takayama K; Nagai T
Biol Pharm Bull; 1998 Jul; 21(7):741-6. PubMed ID: 9703260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
